CD34+CD19-, CD34+CD19+ and CD34-CD19+ cells may all have leukemia-initiating potential in NOD/Scid mice.

被引：0
|
作者：
Le Viseur, Christoph
Hotfilder, Marc
Rosemann, Annepret
Stam, Ronald
Schrauder, Andre
Shultz, Leonard
Schrappe, Martin
Pieters, Rob
Vormoor, Josef
机构：
[1] Univ Munster, Dept Pediat Hematol Oncol, D-4400 Munster, Germany
[2] MC Sophia Childrens Hosp, Dept Pediat Hematol Oncol, Rotterdam, Netherlands
[3] Univ Schleswig Holstein, Dept Pediat, Kiel, Germany
[4] Jackson Lab, Bar Harbor, ME 04609 USA
[5] Univ Newcastle Upon Tyne, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2542.2542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2542
引用
收藏
页码：719A / 719A
页数：1
相关论文
共 50 条
  • [1] CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL
    Kong, Y.
    Yoshida, S.
    Saito, Y.
    Doi, T.
    Nagatoshi, Y.
    Fukata, M.
    Saito, N.
    Yang, S. M.
    Iwamoto, C.
    Okamura, J.
    Liu, K. Y.
    Huang, X. J.
    Lu, D. P.
    Shultz, L. D.
    Harada, M.
    Ishikawa, F.
    LEUKEMIA, 2008, 22 (06) : 1207 - 1213
  • [2] CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL
    Y Kong
    S Yoshida
    Y Saito
    T Doi
    Y Nagatoshi
    M Fukata
    N Saito
    S M Yang
    C Iwamoto
    J Okamura
    K Y Liu
    X J Huang
    D P Lu
    L D Shultz
    M Harada
    F Ishikawa
    Leukemia, 2008, 22 : 1207 - 1213
  • [3] Bafilomycin A1 targets patient-derived CD34+CD19+ leukemia stem cells
    Xu, Li
    Yuan, Na
    Liu, Hong
    Fang, Yixuan
    Ge, Chaorong
    Xu, Fei
    An, Ni
    Wei, Wen
    Li, Lei
    Ji, Li
    Zhang, Xiaoying
    Meng, Jiahao
    Zhang, Suping
    Zhao, Yun
    Chen, Zixing
    Chen, Suning
    Wu, Depei
    Wang, Jianrong
    HAEMATOLOGICA, 2020, 105 (01) : E17 - E21
  • [4] Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia
    Aoki, Yuki
    Watanabe, Takashi
    Saito, Yoriko
    Kuroki, Yoko
    Hijikata, Atsushi
    Takagi, Masatoshi
    Tomizawa, Daisuke
    Eguchi, Mariko
    Eguchi-Ishimae, Minenori
    Kaneko, Akiko
    Ono, Rintaro
    Sato, Kaori
    Suzuki, Nahoko
    Fujiki, Saera
    Koh, Katsuyoshi
    Ishii, Eiichi
    Shultz, Leonard D.
    Ohara, Osamu
    Mizutani, Shuki
    Ishikawa, Fumihiko
    BLOOD, 2015, 125 (06) : 967 - 980
  • [5] Quantitative engraftment capacities of human CD34+ vs. CD34- stem/progenitor cells in nod/scid mice.
    Gao, ZG
    Lumkul, R
    Civin, CI
    BLOOD, 1999, 94 (10) : 31A - 31A
  • [6] Immature CD34+CD19- cells in TEL/AML1-positive ALL are genetically and functionally normal.
    Vormoor, J
    Hotfilder, M
    Röttgers, S
    Rosemann, A
    Harbott, J
    Jürgens, H
    BLOOD, 2001, 98 (11) : 314A - 314A
  • [7] Proportions of cells expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+in the regenerating bone marrows during complete remission of acute leukemia or after bone marrow transplantation
    Kahng, Jimin
    Shin, So-Young
    Han, Kyungja
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2007, 27 (06): : 406 - 413
  • [8] Cord blood CD34+CD38-Lin- progenitors generated from CD34-CD38-Lin- cells engraft NOD/SCID mice in vivo.
    Lamming, CE
    Verfaillie, CM
    BLOOD, 2001, 98 (11) : 850A - 851A
  • [9] Both CD34+ and CD34- cells have the potential to differentiate to natural killer cells
    Lu, J
    Patrene, KD
    Herberman, RB
    Boggs, SS
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 773 - 773
  • [10] S-aureus superantigen protein A expands CD4+/CD8+/CD19+/CD34+ cells in mice:: A potential immunorestorer
    Ghosh, AK
    Sinha, P
    Das, T
    Sa, G
    Ray, PK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (01) : 142 - 146
12345